Default company panoramic image
Expesicor logo fnl

Expesicor

We're developing next generation therapies and diagnostic tools for neurological disorders.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Kalispell, MT, US
  • Currency USD
  • Founded March 2016
  • Employees 3
  • Incorporation Type C-corp
  • Website expesicor.com

Company Summary

• Expesicor is developing next generation therapies and diagnostic tools for neurological disorders, primarily neurodegenerative disorders and epilepsy.

• Our Development Pipeline has two late-stage preclinical candidates (repurposed drug & imaging probe) and others under development.

• Our growing Intellectual Property portfolio has three pending patents & two trademarks

Team

  • Neuroscientist with substantial experience in preclinical R&D. Alzheimer’s Drug Discovery Foundation Young Investigator Award, CURE Epilepsy Foundation Challenge Award, NIH Young Investigator Award.